Skip to Content
Merck
  • Core 1 O-N-acetylgalactosamine (O-GalNAc) glycosylation in the human cell nucleus.

Core 1 O-N-acetylgalactosamine (O-GalNAc) glycosylation in the human cell nucleus.

Biological chemistry (2020-04-17)
Romina B Cejas, Yohana C Garay, Sofia de la Fuente, Ricardo D Lardone, Fernando J Irazoqui
ABSTRACT

Glycosylation is a very frequent post-translational modification in proteins, and the initiation of O-N-acetylgalactosamine (O-GalNAc) glycosylation has been recently described on relevant nuclear proteins. Here we evaluated the nuclear incorporation of a second sugar residue in the biosynthesis pathway of O-GalNAc glycans to yield the terminal core 1 glycan (C1G, Galβ3GalNAcαSer/Thr). Using confocal microscopy, enzymatic assay, affinity chromatography, and mass spectrometry, we analyzed intact cells, purified nuclei and soluble nucleoplasms to identify the essential factors for C1G biosynthesis in the cell nucleus. The enzyme C1GalT1 responsible for C1G synthesis was detected inside the nucleus, while catalytic activity of C1Gal-transferase was present in nucleoplasm and purified nuclei. In addition, C1G were detected in the nucleus inside of intact cells, and nuclear proteins exposing C1G were also identified. These evidences represent the first demonstration of core 1 O-GalNAc glycosylation of proteins in the human cell nucleus. These findings reveal a novel post-translational modification on nuclear proteins, with relevant repercussion in epigenetic and chemical biology areas.

MATERIALS
Product Number
Brand
Product Description

Supelco
Streptavidin, immobilized on Agarose CL-4B, suitable for affinity chromatography
Sigma-Aldrich
Neuraminidase from Clostridium perfringens (C. welchii), Suitable for manufacturing of diagnostic kits and reagents, Type V, lyophilized powder